Lack of Mof reduces acute liver injury by enhancing transcriptional activation of Igf1

J Cell Physiol. 2021 Sep;236(9):6559-6570. doi: 10.1002/jcp.30332. Epub 2021 Feb 26.

Abstract

Acute liver injury (ALI) is a rapid pathological process that may cause severe liver disease and may even be life-threatening. During ALI, the function of males absent on the first (MOF) has not yet been elucidated. In this study, we unveiled the expression pattern of MOF during carbon tetrachloride (CCl4 )-induced ALI and role of MOF in the regulation of liver regeneration. In the process of ALI, MOF is significantly overexpressed in the liver injury area. Knockdown of Mof attenuated CCl4 -induced ALI, and promoted liver cell proliferation, hepatic stellate cell activation and aggregation to the injured area, and liver fibrosis. Simultaneously, overexpression of Mof aggravated liver dysfunction caused by ALI. By directly binding to the promoter, MOF suppressed the transcriptional activation of Igf1. Knockdown of Mof promotes the expression of Igf1 and activates the Insulin-like growth factor 1 signaling pathway in the liver. Through this pathway, Knockdown of Mof reduces CCl4 -induced ALI and promotes liver regeneration. Our results provide the first demonstration for MOF contributing to ALI. Further understanding of the role of MOF in ALI may lead to new therapeutic strategies for ALI.

Keywords: IGF-1; MOF; acute liver injury (ALI); carbon tetrachloride (CCl4); liver regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adenoviridae / metabolism
  • Animals
  • Carbon Tetrachloride
  • Cell Line, Tumor
  • Gene Knockdown Techniques
  • Histone Acetyltransferases / metabolism*
  • Imidazoles / pharmacology
  • Insulin-Like Growth Factor I / genetics*
  • Insulin-Like Growth Factor I / metabolism
  • Liver / drug effects
  • Liver / injuries*
  • Liver / metabolism*
  • Liver / pathology
  • Liver Regeneration / drug effects
  • Liver Regeneration / genetics
  • Mice
  • Mice, Inbred C57BL
  • Promoter Regions, Genetic / genetics
  • Protein Binding / drug effects
  • Pyrazines / pharmacology
  • Signal Transduction / drug effects
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / genetics*

Substances

  • 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
  • Imidazoles
  • Pyrazines
  • Insulin-Like Growth Factor I
  • Carbon Tetrachloride
  • Histone Acetyltransferases
  • Kat8 protein, mouse